This inventor holds 2 USPTO granted patents. Top assignee: Sanofi. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Thomas Priem: Innovator in Sulfonamidobenzofuran Derivatives
Introduction
Thomas Priem is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the development of sulfonamidobenzofuran derivatives. With a total of 2 patents to his name, Priem continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Priem's latest patents include a process for preparing sulfonamidobenzofuran derivatives. This invention relates to a method for synthesizing 5-sulfonamido-benzofuran derivatives, where R represents an alkyl or aryl group. The process involves coupling a benzofuran derivative with a sulfonamide derivative in the presence of a basic agent and a catalyst system formed from a complex between a palladium compound and a ligand.
Another significant patent is a method for preparing 3-keto-benzofurane derivatives. This method also involves coupling a derivative with a sulfonamide derivative, utilizing similar conditions as his previous invention. These innovations showcase Priem's expertise in chemical synthesis and his commitment to advancing the field.
Career Highlights
Thomas Priem is currently employed at Sanofi, a global healthcare company. His work at Sanofi allows him to collaborate with leading professionals in the industry and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Priem has worked alongside talented colleagues such as Philippe Vayron and Fréderic Bailly. These collaborations have further enriched his research and have led to significant advancements in their respective fields.
Conclusion
Thomas Priem is a distinguished inventor whose work in sulfonamidobenzofuran derivatives has made a lasting impact in the field of chemistry. His innovative patents and collaborations reflect his dedication to scientific advancement and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
